Sign up to save your podcasts
Or
Share John Myburgh talks fluid trials and PLUS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
John Myburgh talks fluid trials and PLUS
The second of my series of podcast interviews with keynote speakers from the 2016 ANZICS CTG meeting in Noosa is with Professor John Myburgh.
John needs little introduction to anyone in the critical care field, with a PhD in catecholamine physiology and a co-author / principle investigator on a number of practice changing papers including the CHEST and SAFE fluid trials.
John joins me to chat about his latest ground-breaking project, the PLUS trial (PlasmaLyte 148 versUs Saline) in ICU patients.
See omnystudio.com/listener for privacy information.
View all episodes
By Todd Fraser
4.7
33 ratings
The second of my series of podcast interviews with keynote speakers from the 2016 ANZICS CTG meeting in Noosa is with Professor John Myburgh.
John needs little introduction to anyone in the critical care field, with a PhD in catecholamine physiology and a co-author / principle investigator on a number of practice changing papers including the CHEST and SAFE fluid trials.
John joins me to chat about his latest ground-breaking project, the PLUS trial (PlasmaLyte 148 versUs Saline) in ICU patients.
See omnystudio.com/listener for privacy information.